SCHEMBL1673163

SCHEMBL1673163

CCOC(=O)c1ccc([Si](OCC)(OCC)OCC)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA12 O43570 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
ESR1 P03372 1/20 0.59
ESR2 Q92731 1/20 0.59
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
MAOA P21397 1/20 0.58
HPGD P15428 4/20 0.51
HTT P42858 2/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
RECQL P46063 1/20 0.49
ALDH1A1 P00352 1/20 0.49
HSP90AA1 P07900 1/20 0.49
CACNA1B Q00975 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87450 0.82 CA1 (0.83) CA1CA2CA12CA7CA9
SCHEMBL2480326 0.81 MAPT (0.45) LMNAHPGDKMT2AALDH1A1NPSR1
SCHEMBL11878293 0.81 CA1 (0.63) CA1CA2CA12CA7CA9
SCHEMBL8380212 0.81 HPGD (0.53) CA1CA2HPGDKMT2AALDH1A1
SCHEMBL27419624 0.80 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL29504635 0.80 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL27667917 0.80 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL7746905 0.80 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL21440358 0.80 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL30271267 0.80 CA1 (0.79) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024076-B2 Alkane Oxidation NORTHWESTERN UNIVERSITY (US) 2015-05-05 US disclosed
US-9024093-B2 Fluorination of organic compounds PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-05-05 US disclosed
US-20140296578-A1 ALKANE OXIDATION NORTHWESTERN UNIVERSITY (US) 2014-10-02 US disclosed
EP-2771118-A1 ALKANE OXIDATION Northwestern University (US) 2014-09-03 EP disclosed
CN-103958058-A Alkane oxidation UNIV NORTHWESTERN 2014-07-30 CN disclosed
US-8545932-B2 Metallization of a porous silicon zone by in situ reduction and application to a fuel cell COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2013-10-01 US disclosed
WO-2013062645-A1 ALKANE OXIDATION NORTHWESTERN UNIVERSITY (US) 2013-05-02 WO disclosed
US-20110312903-A1 FLUORINATION OF ORGANIC COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2011-12-22 US disclosed
US-20110086165-A1 METALLIZATION OF A POROUS SILICON ZONE BY IN SITU REDUCTION AND APPLICATION TO A FUEL CELL COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312903-A1 FLUORINATION OF ORGANIC COMPOUNDS SLCO1B3, SLCO2B1, FLI1 CA1 779/4885CA2 2244/4885CA12 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.